High-Altitude Illnesses & Hypobaric Emergencies
Comprehensive emergency evaluation and protocolized management of high-altitude and hypobaric hypoxia emergencies: the physics of hypobaric hypoxia and the alveolar gas equation; diagnostic validation of Acute Mountain Sickness (AMS) using the Lake Louise Scoring System; life-threatening High Altitude Cerebral Edema (HACE: cytotoxic and vasogenic brain swelling, truncal ataxia, encephalopathy, and high-dose Dexamethasone); High Altitude Pulmonary Edema (HAPE: patchy hypoxic pulmonary vasoconstriction, non-cardiogenic pulmonary hypertension, Nifedipine, and PDE-5 inhibitors); portable hyperbaric chamber (Gamow Bag) protocols; and acetazolamide prophylaxis.
Resuscitation Quick Actions • First 2 Minutes
The Golden Rule of Altitude
Descent of 500 to 1,000 meters is the primary definitive treatment; do NOT delay descent for medications or diagnostics
HACE Hallmark = Ataxia
Truncal ataxia (inability to perform tandem heel-to-toe walking) in an acclimatizing climber is HACE until proven otherwise -> Stat Dexamethasone and descent
HACE Pharmacotherapy
Dexamethasone 8 mg PO/IM/IV loading dose, followed by 4 mg every 6 hours until descent is accomplished and symptoms resolve
HAPE Leading Killer
HAPE is the #1 cause of death from altitude illness: patchy pulmonary vasoconstriction causes hydrostatic alveolar leakage -> Nifedipine 30 mg ER BID
Gamow Bag Protocol
Pressurize portable hyperbaric bag to 2.0 psi (105 mmHg above ambient) with foot pump, continuously venting CO2; provides equivalent of 1,500m descent
Acetazolamide Prophylaxis
Acetazolamide 125 mg PO BID started 24 hours prior to ascent: carbonic anhydrase inhibition causes renal bicarbonate excretion, inducing metabolic acidosis that stimulates nocturnal ventilation
Bottom-Line Clinical Pearl
At high altitude (> 2,500 meters/8,000 feet), **IMMEDIATE DESCENT IS THE SINGLE DEFINITIVE, LIFE-SAVING THERAPY** for High Altitude Cerebral Edema (HACE) and High Altitude Pulmonary Edema (HAPE); never allow a patient with neurological symptoms, ataxia, or dyspnea at rest to remain at altitude or ascend further. When descent is prevented by terrain or severe blizzard conditions, place the patient immediately into a Portable Hyperbaric Chamber (Gamow Bag) pressurized to 2.0 psi (simulating an immediate 1,500-meter descent) and administer **Dexamethasone** (8 mg load, then 4 mg q6h) for HACE, or **Nifedipine extended-release** (30 mg PO BID) with high-flow oxygen for HAPE.
The fraction of inspired oxygen (FiO2) remains constant at 21% at all altitudes. However, barometric pressure decreases exponentially with increasing elevation: at the summit of Mount Everest (8,848 meters), barometric pressure is approximately one-third of sea level (~253 mmHg), resulting in a severely diminished inspired partial pressure of oxygen (PiO2 ~43 mmHg). Hypobaric hypoxia triggers hyperventilation, respiratory alkalosis, and compensatory physiological acclimatization:
| Altitude Category | Elevation in Meters (Feet) | Physiological Stress & Clinical Risk |
|---|---|---|
| High Altitude | 1,500 to 3,500 meters (5,000 to 11,500 feet) | Decreased exercise performance, mild hypoxemia. Acute Mountain Sickness (AMS) is common with rapid ascent above 2,500 meters. |
| Very High Altitude | 3,500 to 5,500 meters (11,500 to 18,000 feet) | Severe hypoxemia during exertion and sleep (periodic Cheyne-Stokes breathing). High risk of HAPE and HACE without proper acclimatization schedules. |
| Extreme Altitude ('Death Zone') | > 5,500 to 8,000+ meters (> 18,000 to 26,000+ feet) | Permanent physiological acclimatization is impossible; progressive progressive tissue catabolism and deterioration. Supplemental oxygen required. |
Acute Mountain Sickness is a self-limiting syndrome that develops 6 to 12 hours after rapid ascent above 2,500 meters (8,000 feet). The 2018 Lake Louise Score requires the presence of a headache plus at least one other systemic symptom:
| Symptom Domain | Clinical Scoring Criteria (0 to 3 Points) | Diagnostic Interpretation |
|---|---|---|
| Headache (MANDATORY) | 0 = None 1 = Mild headache 2 = Moderate headache 3 = Severe, incapacitating headache | Headache must be present in the setting of recent ascent to establish a diagnosis of AMS. |
| Gastrointestinal Symptoms | 0 = Good appetite 1 = Poor appetite or nausea 2 = Moderate nausea or vomiting 3 = Severe nausea and vomiting, incapacitating | Total Lake Louise Score: - 3 to 5 Points: Mild AMS (rest, do not ascend, analgesics, acetazolamide) - 6 to 12 Points: Severe AMS (requires descent or dexamethasone). |
| Fatigue/Weakness | 0 = Not tired 1 = Mild fatigue 2 = Moderate fatigue 3 = Severe fatigue, bedridden | Fatigue must be differentiated from simple exhaustion by persistence after rest. |
| Dizziness/Lightheadedness | 0 = None 1 = Mild 2 = Moderate 3 = Severe, incapacitating | Evaluate balance; if overt ataxia is present, reclassify immediately as HACE! |
| Condition | Pathophysiology & Hallmarks | Emergency Action & Targeted Pharmacotherapy |
|---|---|---|
| High Altitude Cerebral Edema (HACE) (End-stage neurological progression of AMS) | Hypoxia causes cerebral autoregulatory failure, elevated microvascular hydrostatic pressure, blood-brain barrier disruption, and cytotoxic and vasogenic cerebral edema. PATHOGNOMONIC HALLMARK: Truncal Ataxia (inability to walk heel-to-toe in a straight line; tandem gait test). Followed by progressive confusion, hallucinations, stupor, and herniation. | IMMEDIATE LIFE-SAVING INTERVENTIONS: 1. IMMEDIATE DESCENT of at least 500 to 1,000 meters. 2. Dexamethasone: 8 mg PO/IM/IV loading dose, then 4 mg every 6 hours until descent and symptom resolution (reduces capillary permeability and cerebral edema). 3. High-flow supplemental oxygen (2-4 L/min targeting SpO2 > 90%). 4. Portable Hyperbaric Chamber (Gamow Bag) if descent is blocked. |
| High Altitude Pulmonary Edema (HAPE) (#1 Cause of Death from Altitude Illness) | Uneven, patchy hypoxic pulmonary vasoconstriction (HPV). Unconstricted pulmonary capillary beds are subjected to massive transmission of pulmonary arterial pressure (pulmonary capillary stress failure), producing non-cardiogenic, hydrostatic alveolar capillary leakage of protein-rich fluid and RBCs. Presentation: Dry cough progressing to severe dyspnea at rest, tachypnea, tachycardia, cyanosis, and pink frothy sputum. | IMMEDIATE LIFE-SAVING INTERVENTIONS: 1. IMMEDIATE DESCENT with minimal physical exertion (carry or evacuate patient; exertion skyrockets pulmonary artery pressure!). 2. Supplemental Oxygen. 3. Nifedipine Extended-Release: 30 mg PO every 12 hours (calcium channel blocker providing potent pulmonary vasodilation, lowering pulmonary artery pressure). 4. Alternative: Tadalafil 20 mg PO BID or Sildenafil 50 mg PO TID (PDE-5 inhibitors). |
| Modality/Protocol | Technical Details & Operational Guidelines | Physiological Pearl & Mechanism |
|---|---|---|
| Gamow Bag/Hyperbaric Chamber | Lightweight fabric cylinder (2.0 psi = 105 mmHg above ambient): 1. Place patient inside chamber with warm clothing and padding. 2. Zip chamber closed and inflate with foot pump to 2.0 psi. 3. Pump continuously (15-20 strokes/min) to flush carbon dioxide. 4. Keep patient inside for at least 2 to 4 hours. | Instantly raises ambient barometric pressure, effectively simulating an immediate physiological descent of 1,500 to 2,000 meters (5,000 feet) within minutes! Reverses severe hypoxemia when physical descent is impossible. |
| Acetazolamide (Diamox) Chemoprophylaxis | Acetazolamide 125 mg PO BID (or 250 mg PO BID for rapid high-ascent profiles): - Initiate 24 hours prior to ascent and continue for 48 hours after reaching peak altitude. | Mechanism: Reversible carbonic anhydrase inhibition in the proximal renal tubule. Causes urinary bicarbonate wasting, inducing a mild metabolic acidosis that stimulates the medullary respiratory center to hyperventilate, eliminating nocturnal periodic breathing and increasing arterial PO2. |
The Continuing Ascent Disaster & The Dexamethasone False Security Trap
The golden rule of high-altitude medicine is absolute: NEVER ASCEND WITH SYMPTOMS OF ALTITUDE ILLNESS, AND DESCENT IMMEDIATELY IF SYMPTOMS WORSEN OR IF ATAXIA DEVELOPS. Disregarding mild mountain sickness and pushing higher to maintain an itinerary converts mild AMS into fatal High Altitude Cerebral Edema (HACE) within 12 to 24 hours. Even more hazardous is the Dexamethasone False-Security Trap: administering Dexamethasone relieves the severe headache and nausea of AMS within hours, giving the climber a false illusion of complete recovery. DEXAMETHASONE DOES NOT ACCLIMATIZE THE PATIENT: it merely suppresses brain swelling. If a climber takes dexamethasone and continues ascending rather than descending, the drug effect will wear off, precipitating fulminant, fatal uncal herniation at extreme altitude where rescue is impossible.
Test Your High-Altitude Illnesses & Hypobaric Emergencies Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Environmental, Wilderness & Hyper/Hypothermic Emergencies
Hypothermia, frostbite, and heat stroke.
Open Protocol Related EM ProtocolSubmersion, Drowning & Diving Emergencies
Decompression sickness, arterial gas embolism, and hyperbaric medicine.
Open Protocol Related EM ProtocolAcute Severe Asthma & COPD Exacerbation
Acute respiratory failure and non-invasive ventilation.
Open Protocol